Company Overview
Callan JMB Inc. operates primarily through its subsidiary, Coldchain Technology Services, LLC, providing specialized thermal management logistics solutions specifically tailored for the life sciences industry. The company focuses on delivering critical services for frozen shipping, which encompasses the transportation of personalized medicine and cell therapies that require strict temperature control to maintain efficacy. This operational focus places the firm within the Industrials sector, specifically in the Integrated Freight & Logistics industry, where it addresses the growing demand for reliable cold chain infrastructure. In terms of scale, the company holds a market capitalization of $5.74M, generates annual revenue of $5.91M, and employs 26 individuals. These financial and operational figures indicate that Callan JMB Inc. is a micro-cap entity with a relatively small revenue base, suggesting it operates as a niche player rather than a dominant force in the broader logistics market.
Financial Health
The company reported a trailing twelve-month revenue of $5.91M, yet this top-line figure is significantly offset by a net income loss of $-6,668,379 and an EBITDA of $-5,641,734. The substantial gap between the $5.91M revenue and the negative net income reveals a cost structure where expenses, including likely high operational costs associated with maintaining thermal logistics infrastructure, far exceed earnings before interest and taxes. Free cash flow stands at $-1,691,551, which indicates that the company is currently burning cash and lacks the immediate financial flexibility to fund operations solely from internal cash generation without external financing. Profitability metrics are strained, with a gross margin of 36.7%, an operating margin of -129.9%, and a profit margin of -112.7%, illustrating that while the core product offering retains significant value, overhead and other expenses are so high that they result in losses exceeding the total revenue generated. The balance sheet shows a cash position of $2.79M against total debt of $2.07M, with a debt-to-equity ratio of 49.60, suggesting the company maintains a conservative liquidity stance where cash reserves exceed debt obligations despite the negative earnings. Additionally, the current ratio is 3.60, indicating a robust ability to cover short-term liabilities with short-term assets, which provides a buffer against immediate liquidity pressures. Return on Equity is -155.3% and Return on Assets is -51.3%, metrics that reveal management is currently unable to generate positive returns on the capital invested or the assets utilized to run the business.
Valuation Assessment
Trailing twelve-month P/E ratio is N/A and forward P/E is also N/A, a situation that implies the market cannot value the stock based on traditional earnings multiples due to the company's current lack of profitability. The absence of positive earnings makes the comparison between trailing and forward P/E ratios impossible, highlighting the speculative nature of the valuation in the absence of earnings growth. The price-to-book ratio is 1.42, which indicates that the market values the company at a 42% premium over its net book value, a discrepancy often seen in companies with intangible assets or specific industry moats that are not fully captured on the balance sheet. Alternative valuation metrics provide further insight, with a price-to-sales ratio of 0.97 and an EV/EBITDA of -0.92, suggesting the market is pricing the company based on its sales potential rather than current earnings power. The stock has traded between a 52-week high of $5.88 and a 52-week low of $1.08, and the current price sits at a level that reflects significant volatility within this wide range, though the exact current price percentage relative to the high is not calculable without the real-time quote. Beta is N/A, meaning there is no historical data provided to determine the stock's price volatility relative to the broader market, which adds another layer of uncertainty to risk assessment.
Growth & Income
Revenue growth year-over-year is 0.8%, while earnings growth year-over-year is N/A, indicating that the company has stabilized its top line but has not yet achieved consistent profitability to measure earnings expansion. Since earnings are not growing in a positive direction, the growth profile is driven entirely by revenue stability rather than operational leverage or margin expansion. For dividend payers, the dividend yield is N/A and the payout ratio is 0.0%, which confirms that the company does not distribute cash to shareholders. For non-dividend payers, the company reinvests all available earnings, or in this case, retains cash to cover losses and fund operations, rather than paying dividends. The overall growth and income profile summarizes as a non-dividend paying micro-cap company that has achieved minimal revenue growth but remains unprofitable, relying on cash reserves to sustain operations until positive earnings are realized.